Development of next generation antivenoms based on mixtures of human antibodies

Cecilie Knudsen, Mikael Rørdam Andersen, Robert Harrison, Nicholas Casewell, Andreas Hougaard Laustsen

    Research output: Contribution to conferencePosterResearchpeer-review

    125 Downloads (Pure)

    Abstract

    With an annual 150,000 deaths and countless amputations and disfigurements,snakebite envenoming is an ever-present threat in many parts of the rural tropicalworld. In sub-Saharan Africa, only 1-2% of victims are treated with antivenom,which is currently based on animal-derived antibodies. Due to their heterologousorigin, antivenoms often provoke serious side effects in human recipients, such asserum sickness and anaphylaxis, which in some cases leads to death.
    Original languageEnglish
    Publication date2016
    Number of pages1
    Publication statusPublished - 2016
    EventSymposium for Biological and Life Science Students (SymBLS) 2016 - Cambridge, United Kingdom
    Duration: 25 Nov 201625 Nov 2016

    Conference

    ConferenceSymposium for Biological and Life Science Students (SymBLS) 2016
    CountryUnited Kingdom
    CityCambridge
    Period25/11/201625/11/2016

    Fingerprint Dive into the research topics of 'Development of next generation antivenoms based on mixtures of human antibodies'. Together they form a unique fingerprint.

    Cite this